APP and Alzheimer disease: The AD group consisted of nine sporadic patients and two patients with familial AD (APP-V717 and PS1-A246E), all of whom received extensive clinical and research characterization and neuropsychological testing (summary data include mini-mental state examination scores [MMSEs]).